Associations of sex hormone-binding globulin and testosterone with diabetes among men and women (the Saku Diabetes study): A case control study

Cardiovascular Diabetology

Volumn 11, Issue , 2012, Pages

  Goto, Atsushi ^a,b,d   Morita, Akemi ^b,c   Goto, Maki ^a,b,d   Sasaki, Satoshi ^e   Miyachi, Motohiko ^b   Aiba, Naomi ^f   Terauchi, Yasuo ^d   Noda, Mitsuhiko ^a   Watanabe, Shaw ^b  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^c KOSHIEN UNIVERSITY   (Japan)

^d YOKOHAMA CITY UNIVERSITY   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f KANAGAWA INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Fatty liver disease; Sex difference; Sex hormone; Sex hormone binding globulin

Indexed keywords

C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; BODY HEIGHT; BODY MASS; BODY WEIGHT; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FAMILY HISTORY; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL ACTIVITY; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; SMOKING; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FASTING; FATTY LIVER; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GLUCOSE TOLERANCE TEST; HUMANS; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84867422495     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-11-130     Document Type: Article

References (33)

1. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2006, 295(11):1288-1299. 10.1001/jama.295.11.1288, 16537739.
2. Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, Rifai N, Buring JE, Gaziano JM, Liu S. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med 2009, 361(12):1152-1163. 10.1056/NEJMoa0804381, 2774225, 19657112.
3. Goto A, Song Y, Chen BH, Manson JE, Buring JE, Liu S. Coffee and caffeine consumption in relation to sex hormone-binding globulin and risk of type 2 diabetes in postmenopausal women. Diabetes 2011, 60(1):269-275. 10.2337/db10-1193, 3012180, 21030499.
4. Ohlsson C, Barrett-Connor E, Bhasin S, Orwoll E, Labrie F, Karlsson MK, Ljunggren O, Vandenput L, Mellstrom D, Tivesten A. High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden. J Am Coll Cardiol 2011, 58(16):1674-1681. 10.1016/j.jacc.2011.07.019, 21982312.
5. Westerink J, Visseren FL. Pharmacological and non-pharmacological interventions to influence adipose tissue function. Cardiovasc Diabetol 2011, 10(1):13. 10.1186/1475-2840-10-13, 3039566, 21276223.
6. Anderson DC. Sex-hormone-binding globulin. Clin Endocrinol 1974, 3(1):69-96.
7. Rosner W, Hryb DJ, Khan MS, Nakhla AM, Romas NA. Sex hormone-binding globulin mediates steroid hormone signal transduction at the plasma membrane. The Journal of steroid biochemistry and molecular biology 1999, 69(1-6):481-485.
8. Kahn SM, Hryb DJ, Nakhla AM, Romas NA, Rosner W. Sex hormone-binding globulin is synthesized in target cells. J Endocrinol 2002, 175(1):113-120. 10.1677/joe.0.1750113, 12379495.
9. Perry JR, Weedon MN, Langenberg C, Jackson AU, Lyssenko V, Sparso T, Thorleifsson G, Grallert H, Ferrucci L, Maggio M, et al. Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes. Hum Mol Genet 2010, 19(3):535-544. 10.1093/hmg/ddp522, 2798726, 19933169.
10. Peter A, Kantartzis K, Machann J, Schick F, Staiger H, Machicao F, Schleicher E, Fritsche A, Haring HU, Stefan N. Relationships of circulating sex hormone-binding globulin with metabolic traits in humans. Diabetes 2010, 59(12):3167-3173. 10.2337/db10-0179, 2992779, 20841609.
11. Stefan N, Kantartzis K, Haring HU. Causes and metabolic consequences of Fatty liver. Endocr Rev 2008, 29(7):939-960. 10.1210/er.2008-0009, 18723451.
12. Lin HY, Xu Q, Yeh S, Wang RS, Sparks JD, Chang C. Insulin and leptin resistance with hyperleptinemia in mice lacking androgen receptor. Diabetes 2005, 54(6):1717-1725. 10.2337/diabetes.54.6.1717, 15919793.
13. Fan W, Yanase T, Nomura M, Okabe T, Goto K, Sato T, Kawano H, Kato S, Nawata H. Androgen receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion. Diabetes 2005, 54(4):1000-1008. 10.2337/diabetes.54.4.1000, 15793238.
14. Sato T, Matsumoto T, Yamada T, Watanabe T, Kawano H, Kato S. Late onset of obesity in male androgen receptor-deficient (AR KO) mice. Biochem Biophys Res Commun 2003, 300(1):167-171. 10.1016/S0006-291X(02)02774-2, 12480537.
15. World Health Organization Definition, diagnosis and classification of diabetes mellitus and its complications. World Health Organization 1999, 31-33. World Health Organization.
16. Sawada N, Iwasaki M, Inoue M, Sasazuki S, Yamaji T, Shimazu T, Tsugane S. Plasma testosterone and sex hormone-binding globulin concentrations and the risk of prostate cancer among Japanese men: A nested case-control study. Cancer science 2010, 101(12):2652-2657. 10.1111/j.1349-7006.2010.01721.x, 20942896.
17. Sodergard R, Backstrom T, Shanbhag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem 1982, 16(6):801-810. 10.1016/0022-4731(82)90038-3, 7202083.
18. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999, 84(10):3666-3672. 10.1210/jc.84.10.3666, 10523012.
19. Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, Ito H, Tominaga M, Oikawa S, Noda M, Kawamura T, et al. International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values. Journal of Diabetes Investigation 2012, 3(1):39-40.
20. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006, 6:33. 10.1186/1471-230X-6-33, 1636651, 17081293.
21. Calori G, Lattuada G, Ragogna F, Garancini MP, Crosignani P, Villa M, Bosi E, Ruotolo G, Piemonti L, Perseghin G. Fatty liver index and mortality: The cremona study in the 15th year of follow-up. Hepatology 2011, 54(1):145-152. 10.1002/hep.24356, 21488080.
22. Balkau B, Lange C, Vol S, Fumeron F, Bonnet F, D.E.S.I.R. GS Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study. BMC Gastroenterol 2010, 10(1):56. 10.1186/1471-230X-10-56, 2898845, 20529259, D.E.S.I.R. GS.
23. Gastaldelli A, Kozakova M, Hojlund K, Flyvbjerg A, Favuzzi A, Mitrakou A, Balkau B, Investigators R. Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology 2009, 49(5):1537-1544. 10.1002/hep.22845, 19291789.
24. Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology 1995, 6(4):356-365. 10.1097/00001648-199507000-00005, 7548341.
25. Kalyani RR, Franco M, Dobs AS, Ouyang P, Vaidya D, Bertoni A, Gapstur SM, Golden SH. The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women. J Clin Endocrinol Metab 2009, 94(11):4127-4135. 10.1210/jc.2009-0910, 2775652, 19789205.
26. Chen BH, Brennan K, Goto A, Song Y, Aziz N, You NC, Wellons MF, Manson JE, White DL, Butch AW, et al. Sex hormone-binding globulin and risk of clinical diabetes in american black, Hispanic, and asian/pacific islander postmenopausal women. Clin Chem 2012, 58(10):1457-1466. 10.1373/clinchem.2012.193086, 22908136.
27. Haffner SM, Valdez RA, Morales PA, Hazuda HP, Stern MP. Decreased sex hormone-binding globulin predicts noninsulin-dependent diabetes mellitus in women but not in men. J Clin Endocrinol Metab 1993, 77(1):56-60. 10.1210/jc.77.1.56, 8325960.
28. Le TN, Nestler JE, Strauss JF, Wickham EP. Sex hormone-binding globulin and type 2 diabetes mellitus. Trends in endocrinology and metabolism: TEM 2012, 23(1):32-40. 10.1016/j.tem.2011.09.005, 22047952.
29. Nestler JE. Sex hormone-binding globulin and risk of type 2 diabetes. N Engl J Med 2009, 361(27):2676-2677.
30. Simo R, Barbosa-Desongles A, Lecube A, Hernandez C, Selva DM. Potential Role of Tumor Necrosis Factor-alpha in Downregulating Sex Hormone-Binding Globulin. Diabetes 2012, 61(2):372-382. 10.2337/db11-0727, 22210320.
31. Kapoor D, Goodwin E, Channer KS, Jones TH. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 2006, 154(6):899-906. 10.1530/eje.1.02166, 16728551.
32. Grossmann M. Low testosterone in men with type 2 diabetes: significance and treatment. J Clin Endocrinol Metab 2011, 96(8):2341-2353. 10.1210/jc.2011-0118, 21646372.
33. Japan Public Health Center-based Prospective Study http://epi.ncc.go.jp/jphc/15/102.html.